London Daily

Focus on the big picture.
Wednesday, Oct 15, 2025

UK health regulator concerned over use of rapid coronavirus tests

UK health regulator concerned over use of rapid coronavirus tests

Exclusive: MHRA says mass testing regime in England ‘a stretch’ of its authorisation for how kits should be used

The UK’s healthcare regulator has expressed concern to the government that its multibillion-pound mass testing programme is “a stretch” of the authorised use of rapid tests, the Guardian has learned.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the lateral flow devices to be used to find coronavirus cases but not to act as a “green light” for people who test negative to enjoy greater freedoms.

The regulator is concerned that people who test negative will be given false reassurance by their result and will let down their guard if they believe they are Covid-free.

There is very little data to show how well the Innova lateral flow devices detect the virus when used as a self-test by someone who has no symptoms. They are being used by millions of people a week in England under the government’s universal testing programme.


Boris Johnson has put mass testing at the centre of his strategy to lift the UK permanently out of lockdown, alongside the vaccine programme. The government has bought millions of the lateral flow tests as part of the £37bn budget for NHS test and trace.

However, the MHRA told officials in the Department of Health and Social Care (DHSC) that the twice-weekly testing regime unveiled earlier this month was “a stretch” of its authorisation for how the tests should be used.

The regulator raised the concerns before and after the programme was announced on 5 April, the Guardian has learned.

The MHRA has authorised LFTs to be used as a “red light” test – to find infectious people and order them to self-isolate – but not as a “green light” test to allow people greater freedoms if they test negative. The regulator is concerned that the government’s universal testing programme blurs the lines between the two.

The concern stems from a lack of data on how well the tests perform when taken by people who do not have Covid-19 symptoms. It is estimated that one in three infected people will display no symptoms of the virus, making it more difficult to track.

A recent Cochrane review – an analysis of 64 studies – found that rapid tests correctly identify on average 58% of people who are infected with the virus but have no symptoms, meaning more than one in three cases are missed. However, this was based on relatively few samples, limiting the conclusions that could be drawn.

The concern is that people will take a one-off test before visiting loved ones indoors, for example, and that they may be carrying the virus even though they have tested negative.

The MHRA is understood to have asked Matt Hancock’s department to provide evidence about the expected accuracy of the test – and how it performs in reality – and to carry out a public information campaign to explain the benefits and the risks of universal testing.

The MHRA said the government was “the legal manufacturer of the test and as such are responsible for the safety and performance of the test whilst it is in use in the UK”.

The regulator said it met government officials regularly “to discuss a range of issues, including the data they collect on performance”, and added: “False negatives carry a risk of unwitting onward transmission. Therefore, even with a negative test result people must continue to follow national and local rules and guidelines including regular handwashing, social distancing and wearing face coverings, where required.”

A million people a day are taking coronavirus tests, with the majority using lateral flow tests that produce a result in about 30 minutes. Use of the tests has risen steadily to about 830,000 a day since 9 April, when every adult in England was encouraged to request free twice-weekly tests to be taken at home in the biggest expansion of the government’s testing programme to date.

A DHSC spokesperson said the department had been clear that nobody should interpret a negative test result or a vaccine dose as a green light to drop their guard and that, regardless of a test or vaccine, people must stick to lockdown rules.

She added: “There is clear evidence that by using rapid testing we are identifying cases we would otherwise not find, allowing people to isolate, so they can prevent further spread of the disease and save lives.”

Innova’s lateral flow devices are cheaper and quicker than the gold-standard PCR tests and are good at finding the most infectious cases and those that might not otherwise be found, but they are more likely to produce erroneous results.

Newsletter

Related Articles

0:00
0:00
Close
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
Bessent Accuses China of Dragging Down Global Economy Amid New Trade Curbs
U.S. Revokes Visas of Foreign Nationals Who ‘Celebrated’ Charlie Kirk’s Assassination
AI and Cybersecurity at Forefront as GITEX Global 2025 Kicks Off in Dubai
DJI Loses Appeal to Remove Pentagon’s ‘Chinese Military Company’ Label
EU Deploys New Biometric Entry/Exit System: What Non-EU Travelers Must Know
Australian Prime Minister’s Private Number Exposed Through AI Contact Scraper
Ex-Microsoft Engineer Confirms Famous Windows XP Key Was Leaked Corporate License, Not a Hack
China’s lesson for the US: it takes more than chips to win the AI race
Australia Faces Demographic Risk as Fertility Falls to Record Low
California County Reinstates Mask Mandate in Health Facilities as Respiratory Illness Risk Rises
Israel and Hamas Agree to First Phase of Trump-Brokered Gaza Truce, Hostages to Be Freed
French Political Turmoil Elevates Marine Le Pen as Rassemblement National Poised for Power
China Unveils Sweeping Rare Earth Export Controls to Shield ‘National Security’
The Davos Set in Decline: Why the World Economic Forum’s Power Must Be Challenged
France: Less Than a Month After His Appointment, the New French Prime Minister Resigns
Hungarian Prime Minister Viktor Orbán stated that Hungary will not adopt the euro because the European Union is falling apart.
Sarah Mullally Becomes First Woman Appointed Archbishop of Canterbury
Mayor in western Germany in intensive care after stabbing
Australian government pays Deloitte nearly half a million dollars for a report built on fabricated quotes, fake citations, and AI-generated nonsense.
US Prosecutors Gained Legal Approval to Hack Telegram Servers
Macron Faces Intensifying Pressure to Resign or Trigger New Elections Amid France’s Political Turmoil
Standard Chartered Names Roberto Hoornweg as Sole Head of Corporate & Investment Banking
UK Asylum Housing Firm Faces Backlash Over £187 Million Profits and Poor Living Conditions
UK Police Crack Major Gang in Smuggling of up to 40,000 Stolen Phones to China
BYD’s UK Sales Soar Nearly Nine-Fold, Making Britain Its Biggest Market Outside China
Trump Proposes Farm Bailout from Tariff Revenues Amid Backlash from Other Industries
FIFA Accuses Malaysia of Forging Citizenship Documents, Suspends Seven Footballers
Latvia to Bar Tourist and Occasional Buses to Russia and Belarus Until 2026
A Dollar Coin Featuring Trump’s Portrait Expected to Be Issued Next Year
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
×